Part of the Asian Pacific Society of Cardiology’s special series of CME-accredited webinars. This edition of the series will discuss the practices to overcome COVID-19, potential challenges and the APSC Consensus Recommendations.
Overcoming COVID-19 – Prof Kai Xu
Sharing of best practices from China: Changes in STEMI Workflow and Practices in response to the COVID-19 pandemic
APSC Consensus Recommendations – Prof Derek Chew
Titration of pharmacotherapy peri-PCI. Recommendations on use of P2Y12i use – escalation/de-escalation
Singapore Update and Review – Dr Jiashen Loh
Current state of Anti-Viral Therapy
Adj Assoc Prof Tan Wei Chieh Jack
Deputy Head and Senior Consultant
National Heart Centre Singapore
President, Asian Pacific Society of Cardiology, Singapore
Prof Kai Xu
Associate Professor
Department of Cardiology, Shenyang Northern Hospital, China
Prof Derek Chew
Matthew Flinders Fellow and Professor in Cardiology
College of Medicine and Public Health, Adelaide, Australia
Dr Jiashen Loh
Consultant in Infectious Disease
Sengkang General Hospital, Singapore
Dr Mahmoud Traina
Staff Physician, Cardiology, Heart & Vascular Institute, Cleveland Clinic, Abu Dhabi
Prof Junya Ako
Interventional Cardiologist, Kitasato University School of Medicine
Sagamihara, Japan
Prof Koji Hasegawa
Director, Division of Translational Research, Kyoto Medical Center, Visiting Professor, University of Shizuoka, Kyoto, Japan, Past President, International Society of Cardiovascular Pharmacotherapy
Dr Doni Firman
Senior Consultant, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia
Dr Alan Fong
Consultant Cardiologist, Sarawak Heart Centre, Head, Clinical Research Centre, Sarawak General Hospital, Kuching, Malaysia
Dr Quang Ngoc Nguyen
Consultant Interventional Cardiology, Vietnam National Heart Institute, Bach-Mai Hospital, Hanoi, Vietnam
Practicing Cardiologists and Cardiology Trainees
Frontiers in Coronary Heart Disease: STEMI Care During COVID Times